Abstract
The modern management of cerebral arteriovenous malformations (AVMs) is based on three therapeutic modalities: microneurosurgery, endovascular embolization, and stereotactic radiosurgery. Embolization facilitates subsequent radiosurgery by reducing the volume of the nidus, prepares the resection of surgically accessible AVMs, and immediately addresses the risks related to associated intra/extranidal aneurysms and arteriovenous fistulas. We discuss in this article the current state of AVM endovascular therapy.
MeSH terms
-
Adult
-
Aged
-
Brain Ischemia / etiology
-
Cerebral Hemorrhage / etiology
-
Child
-
Clinical Trials as Topic
-
Combined Modality Therapy
-
Cyanoacrylates
-
Embolization, Therapeutic* / methods
-
Enbucrilate
-
Female
-
Humans
-
Intracranial Arteriovenous Malformations / diagnosis
-
Intracranial Arteriovenous Malformations / surgery
-
Intracranial Arteriovenous Malformations / therapy*
-
Male
-
Neurosurgical Procedures
-
Polyvinyls
-
Postoperative Complications
-
Radiosurgery*
-
Stroke / etiology
Substances
-
Cyanoacrylates
-
Polyvinyls
-
ethylene-vinyl alcohol copolymer
-
Enbucrilate